Looking back at 63 patients treated for a brain germinoma
Original title: Patterns of relapse and survival outcomes in patients with intracranial germinoma treated with whole-ventricle irradiation and tumor boost: a single-institution retrospective cohort study.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This kind of radiation is already standard care that doctors give today.
The short version
Most patients in this study were still alive 7 years after radiation.
What was studied. Doctors looked back at 63 patients treated for a brain tumor called germinoma. All had radiation to the brain's fluid spaces, then an extra dose at the tumor.
What they found. Six patients (9.5%) had the tumor come back. Most returns were far from the first spot, in the spine or brain lining. At 7 years, 86.5% of patients were alive.
What this means, and what it doesn't
What it could mean: This treatment controlled the tumor well where it first started. Checkups still need to go on for years. Returns can show up late and in other places.
What it doesn't mean: This was a look back at old records at one hospital. It was not a trial and not a new treatment. It does not promise that every patient will do this well. It is not a cure. Your own plan depends on your tumor and your doctor.
Source: PubMed, November 5, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.